InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.03
(
-0.01%
)
US TECH 100
17,728.40
(
0.26%
)
Dow Jones
39,468.14
(
-0.11%
)
Brent Oil
82.86
(
0.57%
)
Bitcoin
63,153.19
(
2.78%
)
Post# of 251804
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 74
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: north40000 post# 193899

Wednesday, 07/29/2015 3:15:59 PM

Wednesday, July 29, 2015 3:15:59 PM

Post# of 251804
MDVN:

The Cowen analyst has been pounding his shoe on the table for weeks saying MDVN is overvalued. He claims peak enzalutamide sales expectations are $3 billion but that it will be closer to $1 billion. Cites lack of penetration into urologist offices.

Sales are currently running at ~$1 billion per year.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up